(Q35739048)

10 August 2017

title

Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years old (English)

1 reference

10 August 2017

Eftyhia Vardas

6

0 references

Edson D. Moreira

object named as

Edson D Moreira

5

0 references

François Coutlée

10

object named as

Francois Coutlee

1 reference

10 August 2017

Richard J Hillman

1

1 reference

10 August 2017

Anna R Giuliano

2

1 reference

10 August 2017

Joel M Palefsky

3

1 reference

10 August 2017

Stephen Goldstone

4

1 reference

10 August 2017

Carlos Aranda

7

1 reference

10 August 2017

Heiko Jessen

8

1 reference

10 August 2017

Daron G Ferris

9

1 reference

10 August 2017

J Brooke Marshall

11

1 reference

10 August 2017

Scott Vuocolo

12

1 reference

10 August 2017

Richard M Haupt

13

1 reference

10 August 2017

Dalya Guris

14

1 reference

10 August 2017

Elizabeth I O Garner

15

1 reference

10 August 2017

publication date

7 December 2011

1 reference

Clinical and Vaccine Immunology

10 August 2017

published in

1 reference

10 August 2017

volume

19

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

261-267

1 reference

Safety and reactogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, 18) L1 viral-like-particle vaccine in older adolescents and young adults

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272915

Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272915

The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272915

Sexual dimorphism of humoral immunity with human vaccines

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272915

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272915

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272915

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272915

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272915

Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16, and 18 by a multiplexed luminex assay

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272915

Estimation of the impact of genital warts on health-related quality of life.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272915

Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272915

Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272915

The male role in cervical cancer

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272915

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

15 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3272915

15 November 2018

Identifiers

DOI

10.1128/CVI.05208-11

1 reference

10 August 2017

1 reference

10 August 2017

1 reference